| scholarly article | Q13442814 |
| P50 | author | Kunihiro Okamura | Q114082577 |
| Mitsutoshi Tamura | Q114292054 | ||
| Serdar Bulun | Q22277212 | ||
| Hironobu Sasano | Q61126397 | ||
| P2093 | author name string | Karen Ferrer | |
| Siby Sebastian | |||
| Bilgin Gurates | |||
| Sijun Yang | |||
| P2860 | cites work | Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 | Q70787131 |
| Immunohistochemical localisation of cyclooxygenase in the human uterus | Q71603499 | ||
| Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases | Q73041199 | ||
| Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes | Q73199262 | ||
| Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice | Q73386832 | ||
| Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis | Q73562927 | ||
| Human cyclooxygenase-2 cDNA | Q24293134 | ||
| Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
| Cyclooxygenase regulates angiogenesis induced by colon cancer cells | Q24336248 | ||
| A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation | Q27860824 | ||
| Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2 | Q28253346 | ||
| Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element | Q28289531 | ||
| Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 | Q28299729 | ||
| AU-rich elements: characterization and importance in mRNA degradation | Q29547896 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor | Q31076639 | ||
| Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases | Q33841391 | ||
| Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. | Q33952839 | ||
| The biochemistry of 3'-end cleavage and polyadenylation of messenger RNA precursors. | Q34243656 | ||
| Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
| Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction | Q36689762 | ||
| Structure of the human cyclo-oxygenase-2 gene | Q36725123 | ||
| Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene | Q36738705 | ||
| Characterization of the promoter of human prostaglandin H synthase-1 gene | Q36775816 | ||
| Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells | Q38287673 | ||
| Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes | Q38348859 | ||
| Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells | Q38349479 | ||
| Is cyclooxygenase-2 the alpha and the omega in cancer? | Q40365138 | ||
| Expression of cyclooxygenase 2 by prostaglandin E(2) in human endometrial adenocarcinoma cell line HEC-1B. | Q40859830 | ||
| Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages | Q40873094 | ||
| Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. | Q41074033 | ||
| Ending the message is not so simple | Q41245633 | ||
| Inhibition of cyclooxygenase: a novel approach to cancer prevention | Q41626074 | ||
| Up-regulation of cyclooxygenase-2 by product-prostaglandin E2. | Q42547341 | ||
| v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor | Q42820538 | ||
| Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells | Q43511440 | ||
| Prostaglandin E2 increases growth and motility of colorectal carcinoma cells | Q43559615 | ||
| Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle | Q43732477 | ||
| Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis | Q44122756 | ||
| Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus | Q47811024 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostaglandin E2 | Q416554 |
| P304 | page(s) | 26208-26216 | |
| P577 | publication date | 2002-05-10 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B. | |
| P478 | volume | 277 |
| Q58565272 | 6-Shogaol reduces progression of experimental endometriosis and regulation of VGEF and inhibition of COX-2 and PGE2-mediated inflammatory responses |
| Q46424625 | Aspirin use and endometrial cancer risk and survival. |
| Q33801778 | Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer |
| Q46567254 | Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. |
| Q40330937 | Hypoxia induced by benign intestinal epithelial cells is associated with cyclooxygenase-2 expression in stromal cells through AP-1-dependent pathway. |
| Q44512882 | IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. |
| Q28173990 | Increased PGE2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of the head and neck |
| Q36509755 | Inflammatory status influences aromatase and steroid receptor expression in endometriosis. |
| Q35107985 | Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling |
| Q36767568 | Local and systemic factors and implantation: what is the evidence? |
| Q38590189 | MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? |
| Q37274380 | Modulation of signaling pathways in prostate cancer by green tea polyphenols |
| Q45165258 | Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. |
| Q38323790 | Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines |
| Q50695828 | Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. |
| Q53201080 | Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte. |
| Q37761617 | Prostaglandin E2: the master of endometriosis? |
| Q89736259 | Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis |
| Q34095034 | Role of progesterone in endometrial cancer |
| Q36172739 | Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management |
| Q37424846 | Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG |
| Q45414539 | The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene |
| Q42991846 | The relationship of COX-2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomas |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
Search more.